Balancing mitochondrial dynamics via increasing mitochondrial fusion attenuates infarct size and left ventricular dysfunction in rats with cardiac ischemia/reperfusion injury
- PMID: 30705107
- DOI: 10.1042/CS20190014
Balancing mitochondrial dynamics via increasing mitochondrial fusion attenuates infarct size and left ventricular dysfunction in rats with cardiac ischemia/reperfusion injury
Retraction in
-
Retraction: Balancing mitochondrial dynamics via increasing mitochondrial fusion attenuates infarct size and left ventricular dysfunction in rats with cardiac ischemia/reperfusion injury.Clin Sci (Lond). 2025 Jun 23;139(12):739. doi: 10.1042/CS20190014_RET. Clin Sci (Lond). 2025. PMID: 40548407 Free PMC article. No abstract available.
Abstract
An uncontrolled balance of mitochondrial dynamics has been shown to contribute to cardiac dysfunction during ischemia/reperfusion (I/R) injury. Although inhibition of mitochondrial fission could ameliorate cardiac dysfunction, modulation of mitochondrial fusion by giving a fusion promoter at different time-points during cardiac I/R injury has never been investigated. We hypothesized that giving of a mitochondrial fusion promoter at different time-points exerts cardioprotection with different levels of efficacy in rats with cardiac I/R injury. Forty male Wistar rats were subjected to a 30-min ischemia by coronary occlusion, followed by a 120-min reperfusion. The rats were then randomly divided into control and three treated groups: pre-ischemia, during-ischemia, and onset of reperfusion. A pharmacological mitochondrial fusion promoter-M1 (2 mg/kg) was used for intervention. Reduced mitochondrial fusion protein was observed after cardiac I/R injury. M1 administered prior to ischemia exerted the highest level of cardioprotection by improving both cardiac mitochondrial function and dynamics regulation, attenuating incidence of arrhythmia, reducing infarct size and cardiac apoptosis, which led to the preservation of cardiac function and decreased mortality. M1 given during ischemia and on the onset of reperfusion also exerted cardioprotection, but with a lower efficacy than when given at the pre-ischemia time-point. Attenuating a reduction in mitochondrial fusion proteins during myocardial ischemia and at the onset of reperfusion exerted cardioprotection by attenuating mitochondrial dysfunction and dynamic imbalance, thus reducing infarct size and improving cardiac function. These findings indicate that it could be a promising intervention with the potential to afford cardioprotection in the clinical setting of acute myocardial infarction.
Keywords: Acute myocardial infarction; Heart; Ischemia-reperfusion injury; Mitochondrial dynamics; Mitochondrial fusion.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
Comment in
-
Targeting mitochondria to protect the heart: a matter of balance?Clin Sci (Lond). 2020 Apr 17;134(7):885-888. doi: 10.1042/CS20200236. Clin Sci (Lond). 2020. Retraction in: Clin Sci (Lond). 2025 Aug 13;139(15):CS20200236_RET. doi: 10.1042/CS20200236_RET. PMID: 32286622 Retracted.
Similar articles
-
Differential temporal inhibition of mitochondrial fission by Mdivi-1 exerts effective cardioprotection in cardiac ischemia/reperfusion injury.Clin Sci (Lond). 2018 Aug 14;132(15):1669-1683. doi: 10.1042/CS20180510. Print 2018 Aug 16. Clin Sci (Lond). 2018. Retraction in: Clin Sci (Lond). 2025 Jun 23;139(12):CS20180510_RET. doi: 10.1042/CS20180510_RET. PMID: 30065084 Retracted.
-
Targeting mitochondria to protect the heart: a matter of balance?Clin Sci (Lond). 2020 Apr 17;134(7):885-888. doi: 10.1042/CS20200236. Clin Sci (Lond). 2020. Retraction in: Clin Sci (Lond). 2025 Aug 13;139(15):CS20200236_RET. doi: 10.1042/CS20200236_RET. PMID: 32286622 Retracted.
-
Mitochondrial dynamic modulation exerts cardiometabolic protection in obese insulin-resistant rats.Clin Sci (Lond). 2019 Dec 20;133(24):2431-2447. doi: 10.1042/CS20190960. Clin Sci (Lond). 2019. PMID: 31808509
-
Beta-blockers in patients without heart failure after myocardial infarction.Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2. Cochrane Database Syst Rev. 2021. PMID: 34739733 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
Cited by
-
Mitochondrial network remodeling of the diabetic heart: implications to ischemia related cardiac dysfunction.Cardiovasc Diabetol. 2024 Jul 18;23(1):261. doi: 10.1186/s12933-024-02357-1. Cardiovasc Diabetol. 2024. PMID: 39026280 Free PMC article. Review.
-
Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection.J Adv Res. 2020 Sep 28;29:33-44. doi: 10.1016/j.jare.2020.09.007. eCollection 2021 Mar. J Adv Res. 2020. PMID: 33842003 Free PMC article.
-
Outcomes of hypothalamic oxytocin neuron-driven cardioprotection after acute myocardial infarction.Basic Res Cardiol. 2023 Oct 6;118(1):43. doi: 10.1007/s00395-023-01013-1. Basic Res Cardiol. 2023. PMID: 37801130 Free PMC article.
-
Mitochondrial dynamics in health and disease: mechanisms and potential targets.Signal Transduct Target Ther. 2023 Sep 6;8(1):333. doi: 10.1038/s41392-023-01547-9. Signal Transduct Target Ther. 2023. PMID: 37669960 Free PMC article. Review.
-
Calenduloside E Ameliorates Myocardial Ischemia-Reperfusion Injury through Regulation of AMPK and Mitochondrial OPA1.Oxid Med Cell Longev. 2020 Aug 31;2020:2415269. doi: 10.1155/2020/2415269. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32934760 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical